Last reviewed · How we verify

NCT02444039

Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment

Completed Last updated 6 June 2022
What this trial tests

trial testing SL-D301 in Any Willing and Able Person for Ocular Imaging in 20 participants. Completed in 1 December 2014.

Timeline
1 November 2014
Primary endpoint
1 December 2014
1 December 2014

Quick facts

Lead sponsorTopcon Medical Systems, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 November 2014
Primary completion1 December 2014
Estimated completion1 December 2014
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Topcon Medical Systems, Inc.

Who can join

18 and older, any sex, with Any Willing and Able Person for Ocular Imaging. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The objective of the study is to compare the ease of use and performance of the SL-D301 with the DC-4 with other existing slit lamps imaging systems (SL-3G) from Topcon.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Topcon Medical Systems, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02444039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing